ALPS Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

ALPS Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-69,773	Closed	-$6.86M	–	958
2018 Q3	$6.86M	Buy	69,773 +11,849	+20%	+$1.28M	0.05%	134
2018 Q2	$6.7M	Buy	57,924 +4,138	+8%	+$455K	0.04%	145
2018 Q1	$5.31M	Buy	53,786 +8,893	+20%	+$901K	0.04%	144
2017 Q4	$4.7M	Buy	44,893 +4,995	+13%	+$549K	0.03%	143
2017 Q3	$4.5M	Buy	39,898 +2,861	+8%	+$311K	0.03%	145
2017 Q2	$4.15M	Buy	37,037 +1,737	+5%	+$196K	0.03%	148
2017 Q1	$4.02M	Sell	35,300 -4,133	-10%	-$457K	0.03%	147
2016 Q4	$4.15M	Buy	+39,433	New	+$4.13M	0.03%	141

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

ALPS Advisors's TARO Position: Q4 2018 in Review

ALPS Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2018, closing a stake of 69,773 shares — an estimated $6.86M sold.

ALPS Advisors first reported a position in TARO in Q4 2016 and held it in 8 quarters. The position peaked at $6.86M in Q3 2018. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2018.

ALPS Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2018 after selling out during the quarter.
ALPS Advisors sold 69,773 Taro Pharmaceutical Industries Ltd. shares in Q4 2018, an estimated $6.86M.
ALPS Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2016 and held it in 8 quarters.
ALPS Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $6.86M in Q3 2018.
94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2018.

Based on ALPS Advisors's 13F filing for Q4 2018, filed 4 Feb 2019.